Abemaciclib,Trastuzumab,Fulvestrant
eli lilly,roche,Astrazeneca
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'abemaciclib', ' fulv', 'bcsm', 'abema', 'breast']
abemaciclib+ trastuzumab, with or without fulvestrant, improved os in women with hormone receptor positive, her2-positive advanced breast cancer vs standard-of-care chemotherapy+trastuzumab. #bcsm #esmo2022 | 
Oncology news and insights from leading researchers and cancer centers.